Upgrade to SI Premium - Free Trial

Goldman Sachs Sees Catalysts for Allergen (AGN) and Adds to Conviction Buy List

May 13, 2016 6:37 AM
(Updated - May 13, 2016 8:58 AM EDT)Goldman Sachs upgraded Allergen (NYSE: AGN) from Buy to Conviction Buy, with a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Hot Comments Upgrades

Next Articles